Dr. Sprung


Dr. Sprung

Douglas J. Sprung, M.D., F.A.C.G., F.A.C.P.

Medical School - Duke University School of Medicine
Residency - Duke University School of Medicine
Fellowship - Lahey Clinic Medical Center


HIGH SCHOOL
Stuyvesant High School, New York, NY
COLLEGE
 New York University, University Heights/Washington Square,
New York, NY – B.A.
MEDICAL SCHOOL
 Duke University School of Medicine, Durham, NC – M.D. May 1980
POST MEDICAL TRAINING

INTERNSHIP:


Internal Medicine – Duke University Medical Center July 1980 – June 1981
RESIDENCY:
 Internal Medicine – Duke University Medical Center July 1981 – June 1983
FELLOWSHIP: Gastroenterology – Lahey Clinic Medical Center, Burlington, MA. July 1983 – June 1985
HONORS: Assistant Chief Medical Resident, Durham VA Medical Center Duke University Medical Center 1983
American College of Gastroenterology Auxiliary Award for the Best Scientific Paper, 49th Annual Scientific Meeting, October 29-31, 1984, Ontario, Toronto, Canada
Fellow American College of Gastroenterology, October 1996, F.A.C.G.
Fellow American College of Physicians, July 1, 1999 F.A.C.P.
MEDICAL SOCIETIES: Member – American College of Physicians
Member – American College of Gastroenterology
Member – American Gastroenterological Association
Member – American Society of Internal Medicine/American College of Physicians
HOSPITAL AFFILIATED:

ADMINISTRATIVE COMMITTEES
MEDICAL TEACHING AND EDUCATION ACTIVITIES:
 Florida Hospital Altamonte and Florida Hospital Orlando

Peer Review Committee, South Seminole Community Hospital, 1991 – 1994
Winter park Ambulatory Surgical Center – Steering Committee,
Vice-President Executive Committee, 1989 – Present
Attending Rounds with Family Practice Residency Program
Florida Hospital System, 1985 – Present
Journal Reviewer, American Journal of Gastroenterology and Annals of Internal Medicine.
PUBLICATIONS:

1. Sprung, D.J., “Milliary Tuberculosis with Adult Respiratory Distress Syndrome and a Leukemoid Reaction”. North Carolina Med J, 1981: 42:709-10.

2. Sprung, D.J., “Sulindac Causing a Hypersensitivity Reaction with Peripheral and Mediastinal Lymphadenopathy”. Ann Intern Med, 1982: 97:564.

3. Sprung, D.J., “Cholesterol, Triglycerides…and a Healthy Heart”. Vogue Magazine, April 1982.

4. Sprung, D.J., “Barrett’s Esophagus: A Surgical Entity?”. Arch Surg. 1984: 119:1216.

5. Sprung, D.J., Ellis, F.H.; Gibb, S.P., “Incidence of Adenocarcinoma in Barrett’s Esophagus”. Am Journal Gastroenterology, 1984: 79:817 (abst).

6. Sprung, D.J.; Ellis, F.H.; Gibb, S.P., “Regression of Barrett’s Epithelium After Anti-Reflux Surgery”. Am J Gastroenterology, 1984: 79:817 (abst).

7. Sprung, D.J.; Gibb, S.P., “Barrett’s Esophagus in a Patient with Acalaisa”. Am J Gast, 1985:80, No.5.

8. Sprung, D.J.; Gibb, S.P., “Dysplastic Barrett’s Esophagus in Scleroderma”. Am J Gast, 1985; 80, No. 7

9. Shafran, I.; Apter, M.N.; Sprung, D.J., “Reasons for Exclusion of Patients in Treatment of NANB Hepatitis”. Gastroenterology, 1995; Vol. 108, No.4:A1167.

10. Sprung, D.J.; Apter, N.N.; “Incidence of Adenocarcinoma in Barrett’s Esophagus – A Community Based Study”. American Journal of Gastroenterology, Sept, 1995: Vol. 90, No. 9, p. 1572.

11. Sprung, D.J.; Apter, M.N.; “Prevalence of Adenocarcinoma of the Esophagus – A Community Based Study”. American Journal of Gastroenterology, Sept. 1995; Vol. 90, No. 9, p. 1572.

12. Sprung, D.J.; Apter, M.N.; “Absence of Helicobacter Pylori in Gastric Carcinoma – A Five Year Community Based Review”. Gastroenterology, April, 1996; Vol. 100, No. 4:A597.

13. Sprung, D.J., Apter, M.N.; “Occurrence of Dysplasia in Barrett’s Esophagus – A Community Based Study”. American Journal of Gastroenterology, Sept, 1996; Vol. 91, No. 9, p. 1899.

14. Sprung, D.J., Apter, M.N., et. al.; “The Prevalence of Helicobacter Pylori in Duodenal Ulcer Disease A Community Based Study. American Journal of Gastroenterology, Sept, 1996; Vol. 91, No. 9, p. 1926.

15. Sprung, D.J., Apter, M.N.; “Low Prevalence of Helicobacter Pylori in Duodenal and Gastric Ulcers Results of a Prospective Community Study”. Gastroenterology, April, 1997, Vol. 112, No. 4:A298.

16. Sprung, D.J., Apter, M.N.; “Clinical Characteristics of Colon Cancer Affecting Younger Patients A Community Based Study”. Gastroenterology, April, 1997; Vol. 112, No. 4:A662.

17. Sprung, D.J., Apter, M.N., “Utility of Surveillance Colonoscopy for Patients Whose First Degree Relatives Have Colon Cancer – A Community Based Study”. Amer J of Gastroenterology, 1997; Vol. 92, No. 9:1689.

18. Sprung, D.J., Gano, Brenda, M.A., “The Natural History of Duodenal Ulcer Disease and How It Relates to H. Pylori – A Community Study”. Am J. of Gastroenterology, 1997; Vol. 92, No. 9:1655.

19. Sprung, D.J., “Consensus Conference on Surveillance for Barrett’s Esophagus”. Amer J of Gastroenterology, 1997, Vol.92, No. 10:1948.

20. Sprung, D.J., Editorial: “Does Helicobacter Pylori Really Cause Ulcers?”. Gastroenterology and Endoscopy News, March, 1997.

21. Sprung, D.J., Editorial: “What Does Low Prevalence of H. Pylori in Duodenal Ulcer Disease Mean?”. Gastroenterology and Endoscopy News, October, 1997; pg. 24.

22. Sprung, D.J., Editorial: “Does H. Pylori Eradication Affect Recurrence Rate of Duodenal Ulcer?”. Gastroenterology and Endoscopy News, January, 1998; pg. 5.

23. Sprung, D.J., Apter, M.N., “What is the Role of Helicobacter Pylori in Peptic Ulcer and Gastric Cancer Outside the Big Cities?”. Clinical Gastroenterology, January, 1998; Vol. 26, No. 1:60-63.

24. Sprung, D.J., “Incidence of Adenocarcinoma and Dysplasia in a Community Based Population of Barrett’s Esophagus”. Gastroenterology, April 15, 1998; Vol. 114, No. 4:A294.

25. Sprung, D.J., “Is Colon Cancer Surveillance Cost Effective for Asymptomatic Patients with a Positive Family History?”. Amer Journal of Gastro, 1998; Vol. 93, No. 9, pg. 1700 (abstract).

26. Sprung, D.J., “H.Pylori: Is It Really Such a Bad Guy After All?” Amer Journ Gastro, 1998: Vol. 93, No. 9, pg. 1596.

27. Sprung, D.J., Gano, B., Apter, M.N., “Do Gastric Ulcers Require Follow-Up Endoscopy.” Gastroenterology, April, 2000; Vol. 188, No. 4, Supp. II, Pg. A1309.

28. Sprung, D.J., “Ulcers Within Barrett’s Esophagus: Not Necessarily an Ominous Sign”. American Journal of Gastroenterology, May, 2000;Vol. 95, No. 9, Pg. 2436.

29. Sprung, D.J., Lundberg, Christina, “Do Surveillance Colonic Biopsies in Patients with Ulcerative Colitis Prevent Cancer in a Community Setting?” American Journal of Gastroenterology, Sep Supplement 2000; Pg. S309.

30. Sprung, D.J., Lundberg, Christina, “Occurrence of Colon Cancer in Ulcerative Colitis, a Community Observation”. American Journal of Gastroenterology, Sept Supplement 2000; Pg. S309.

31. Sprung, D.J., Sprung, G.M., “Barrett’s Esophagus in our Community over the Past Twelve Years”. American Journal of Gastroenterology, 2003, Vol. 98, No. 1, Supplement: S-1.

32. Sprung, D.J., Sprung, G.M., "Colon Cancer in the Community: Occurrence Recurrence and Characteristics in a One Year Review." American Journal of Gastroenterology, Nov 2004, Vol. 99, No. 10, Pg. S106.

33. Sprung, D.J., Sprung, G.M., "Colonoscopy in the Community: Findings of a One Year Review." American Journal of Gastroenterology, Nov. 2004, Vol. 99, No. 10, Suppl Page S324.

34. Sprung, D.J., Sprung, G.M. "Low Prevalence of H. Pylori Associated Gastric Carcinoma in a Community Based Population: A 15 Year Review." American Journal of Gastroenterology, Sept. 2005, Vol. 100, No. 9, Suppl. S55.

35. Sprung, D.J. "Endoscopic Appearance of the Terminal Ileum in 100 Normal Patients." American Journal of Gastroenterology, Sept. 2005, Vol. 100, No. 9, Suppl. S94.

36. Sprung, D.J. "Relationship of Ischemic Colitis, Irritable Bowel Syndrome and Hyperectomies: A Community Study." American Journal of Gastroenterology, Sept. 2005, Vol. 100, No. 9, Suppl. S150.

37. Sprung, D.J., Wagner M., Mulcahy, D. "Observed Colonoscopic Withdrawal Time from the Cecum to the Anus in a Community Setting." American Journal of Gastroenterology, Sept. 2005, Vol. 100, No. 9, Suppl. S348.

38. Sprung, D.J., Sprung, G.M. Lymphocytic and Collagenous Colitis in a Community Setting: A 10 Year Review. American Journal of Gastroenterology, Sept 2005, Vol. 100, No. 9, Suppl. S290.

39. Sprung, D.J. "The Risk of Colorectal Cancer in Ulcerative Colitis in a Population-Based Setting." Gastroenterology 2006; 131:684-685.

40. Sprung, D.J., Sprung G.M. "Rapidly Rising Prevalence of Microscopic Colitis." American Journal of Gastroenterology, Sept 2006, Vol. 101, No. 9, p.s201.

41. Sprung, D.J. "Does the Timing of Laxatives make a Difference in Colonoscopy Prep Outcomes?" American Journal of Gastroenterology, Sept 2006, Vol. 101, No. 9, p.s398.

42. Sprung, D.J., Sprung, G.M. "Declining Prevalence of New Cases of Ulcerative Colitis." American Journal of Gastroenterology, Sept 2006, Vol. 101, No. 9, p.s427.

43. Sprung, D.J. "Prevalence of Barrett's Esophagus among Symptomatic Patients in a Community GI Practice." American Journal of Gastroenterology, Sept 2006, Vol. 101, No. 9, p.s45.

44. Sprung, D.J. "Prevalence of Adenocarcinoma in Small Adenomas." American Journal of Gastroenterology, Sept 2006, Vol. 101, No. 9, p.s199.

45. Sprung, D.J., Sprung, G.M. "Is the Risk of Colon Rectal Cancer Elevated in Chronic Ulcerative Colitis in the community?" American Journal of Gastroenterology, April 2007, Vol. 132, No. 4, Suppl 2, p. 348.

46. Sprung, D.J., FACP, FACG. "The Obese Refluxer: Nothing New Under the Sun." Annals of Internal Medicine: Electronic Letters to the Editor, August 15, 2005.

47. Sprung, D.J., FACP, FACG. "Family History as a Risk Factor for Colon Cancer: Data from the Community." Annals of Internal Medicine: Electronic Letters to the Editor. August 15, 2005.

48. Sprung, D.J., Sprung, G.M. "Celiac Disease in the Adult Community: Still a Rare Occurrence." American Journal of Gastroenterology, Sept 2007, Vol. 102, No. S2, p.S201.

49. Sprung, D.J. "Antispasmotics are Safe for Treating Irritable Bowel Patients Age 65 and Older in the Community." American Journal of Gastroenterology, Sept 2007, Vol. 102, No. S2, p.S429.

NATIONAL SOCIETY PRESENTATIONS:
 
American College of Gastroenterology 49th Annual Scientific Meeting, Oct 29-31, 1984, Ontario, Toronto, Canada, Sprung, D.J., Ellis, F.H.; Gibb, S.P., “Incidence of Adenocarcinoma in Barrett’s Esophagus”. Sprung, D.J., Ellis, F.H.; Gibb, S.P., “Regression of Barrett’s Epithelium After Anti-Reflux Surgery”.

American College of Gastroenterology 50th Annual Scientific Meeting, October 9, 1985 Miami, Florida Sprung, D.J., Gibb, S.P., “The Prevalence of Barrett’s Esophagus in Scleroderma”.

American College of Gastroenterology Annual Meeting, October, 1995 – New York City. Sprung, D.J., Shafran, Apter, “Incidence of Adenocarcinoma in Barrett’s Esophagus A Community Based Study”. Sprung, D.J., Shafran, Apter, “Prevalence of Adenocarcinoma of the Esophagus – A Community Based Study”.

American Gast. Association Digestive Disease Week Annual Meeting – Poster Session May, 1996 San Francisco. Sprung, D.J.; Apter, M.N., “Absence of H. Pylori in Gastric Carcinoma – A Five Year Community Based Study”.

American College of Gastroenterology Annual Meeting, Poster Session, October, 1996 Seattle, Washington Sprung, D.J.; Apter, M.N., et al., “The Prevalence of Helicobacter Pylori in Duodenal Ulcer Disease – A Community Based Study”.

American College of Gastroenterology Annual Meeting, Poster Session, October, 1996 Seattle, Washington. Sprung, D.J.; Apter, M.N., “The Occurrence of Dysplasia in Barrett’s Esophagus – A Community Based Study”.

American College of Gastroenterology Annual Meeting, Poster Session, November 1-5, 1997 Chicago, IL.
Sprung, D.J.; Gano, Brenda, “The Natural History of Duodenal Ulcer Disease and How It Relates to H. Pylori – A Community Study”.

American College of Gastroenterology Annual Meeting, Poster Session, November 1-5, 1997 Chicago, IL.
Sprung, D.J., Apter, M.N., “The Utility of Surveillance Colonoscopy for Patients Whose First Degree Relatives Have Colon Cancer – A Community Based Report”.

DDW-AGA, Poster Session, May 20, 1998 New Orleans, Louisiana. Sprung, D.J., “Incidence of Adenocarcinoma and Dysplasia in a Community Based Population with Barrett’s Esophagus”.

American College of Gastroenterology Annual Meeting, Poster Session, October 13, 1998 Boston, MA.
Sprung, D.J., “Is Colon Cancer Surveillance Cost Effective for Asymptomatic Patients with a Positive Family History?”.

American College of Gastroenterology Annual Meeting, Poster Session, October 15-18, 2000 – NY, NY. Sprung, D.J., “Ulcers Within Barrett’s Esophagus: Not Necessarily an Ominous Sign”.

American College of Gastroenterology Annual Meeting, October 2001, Las Vegas, Nevada
Sprung, D.J., Lundberg, Christina, “Do Surveillance Colonic Biopsies in Patients with Ulcerative Colitis Prevent Cancer in a Community Setting?” American Journal of Gastroenterology, Sep Supplement 2000; Pg. S309.

American College of Gastroenterology Annual Meeting, October 2001 – Las Vegas, Nevada Sprung, D.J., Lundberg, Christina, “Occurrence of Colon Cancer in Ulcerative Colitis, a Community Observation”. American Journal of Gastroenterology, Sept Supplement 2000; Pg. S309.

American College of Gastroenterology Annual Meeting, Poster Session October 2003 – Baltimore, MD. Sprung, D.J., Sprung, G.M., “Barrett’s Esophagus in the Community over the Past 12 Years”.

American College of Gastroenterology Annual Meeting, Poster Session, November 1-3, 2004 - Orlando, FL. Sprung, D.J., Sprung, G.M., "Colon Cancer in the Community: Occurrence, Recurrence and Characteristics in a One Year Review."

American College of Gastroenterology 70th Annual Meeting, 10/30/05, Honolulu, Hawaii. Sprung, D.J., Sprung, G.M., “Low Prevalence of H. Pylori Associated Gastric Carcinoma in a Community Based Population; A 15 year review.”

American College of Gastroenterology 70th Annual Meeting, 11/1/05, Honolulu, Hawaii. Sprung, D.J., “Observed Colonoscopic Withdrawal Time from the Cecum to the Anus in a Community Setting.”

American College of Gastroenterology 70th Annual Meeting, 11/1/05, Honolulu, Hawaii. Sprung, D.J., “Endoscopic Appearance of the Terminal Ileum in 100 Normal Patients.”

American College of Gastroenterology 71st Annual Meeting, 10/24/06, Las Vegas, Nevada. Sprung, D.J., Sprung, G.M. "Rapidly Rising Prevalence of Microscopic Colits."

American College of Gastroenterology 71st Annual Meeting, 10/22/06, Las Vegas, Nevada. Sprung, D.J. "Does the Timing of Laxatives Make a Difference in Colonoscopy Prep Outcomes?"

American College of Gastroenterology 71st Annual Meeting, 10/24/06, Las Vegas, Nevada. Sprung, D.J. "Prevalence of Barrett's Esophagus among Symptomatic Patients in a Community GI Practice."

American Gastroenterological Association, DDW May 2007, Washington, D.C. Sprung, D.J., Sprung, G.M. "Is the Risk of Colon Rectal Cancer Elevated in Chronic Ulcerative Colitis in the Community?"

American College of Gastroenterology. Oct 16, 2007, Philadelphia, Pennsylvania. Sprung, D.J., Sprung, G.M. "Celiac Disease in the Adult Community: Still a Rare Occurrence."

LECTURES:

Duke University Medical Center 1984 Medical Alumnae Invitational Symposium, November 8-10, 1984 “Incidence of Adenocarcinoma in Barrett’s Esophagus”.

Florida Gastroenterologoical Society, Naples, Registry Hotel, October, 1988 “Importance of Campylobacter Pylori”.
Surgical Gastroenterologoical Nurses Association, April, 1995 – “Gastroesophageal Reflux and Peptic Ulcer Disease”.

Surgical Gastroenterologoical Nurses Association, April 1996 – “Highlights of Incidence of Adenocarcinoma in Barrett’s Esophagus and Prevalence of Esophageal Cancer in our Community”.

Gastroenterological Nurses Association, September, 1997 – “Incidence and Prevalence of Adenocarcinoma In Barrett’s Esophagus: A Ten Year Study in the Orlando Community”.

Surgical Gastroenterological Nurses Association, March, 1998 – “Helicobacter Pylori in the Orlando Community Setting: Incidence and Prevalence in Duodenal Ulcer, Gastric Ulcer and Gastric Cancer”.

Astra-Merck Lecture, Morton’s Chicago Steakhouse, September 10, 1998 for local family physicians – “Clinical Pearls and Case Studies in Gastroesophageal Reflux Disease”.

Duke University Medical Center, Department of Gastroenterology, March, 1999: Gastrointestinal Grand Rounds – “What is the Role of Helicobacter Pylori in Peptic Ulcer Disease and Gastric Cancer?”.

RESEARCH PROJECTS:

4/96 – 4/98 – “Acid Peptic Disorder Project” sponsored by Astra Merck Pharmaceutical in coordination with Cedars Sinai consultation and Shands Hospital consultation. I served as GI consultant to the Orlando HealthCare Group – PruCare HMO for set-up and implementation of this project. This Involved biweekly meetings and intermittent executive committee meetings. Meetings.

8/96 – “Helicobacter and Peptic Ulcer Disease Investigation”. These are clinical investigations sponsored by Proctor & Gamble and Boyer Medical Group. The purpose is to evaluate treatment efficacy of the new Helindac therapy sponsored by Proctor & Gamble in treatment of Helicobacter pylori infestation in peptic ulcer disease.

2/97 – “A Double Blind Positive Controlled Randomized parallel Study to Evaluate the Effects of Lansoprazole Compared with Ranitidine on NSAID – Induced Gastric Ulcers in Patients Continuing to Take NSAIDs”, clinical trial sponsored by TAP Holdings, Inc. Protocol no. M95-352.

1/98 – 4/98 – “Chronic Dyspepsia Study”. TAP Holding Pharmaceutical Company. Endoscopic evaluation of patients with a greater than three month history of dyspepsia for a trial of a new experimental promotility agent.

4/99 – 10/99 – “TAP M98-890 GERD II Study”. TAP Holding Pharmaceutical Company. Compare in a randomized and blinded fashion the use of Prevacid versus Prilosec in patients with Grade II exophagitis or more severe esophagitis. Evaluation and endoscopy were performed on all patients.

5/99 – 12/99 – “Osteoarthritis Study 1004-031-050”. Parke-Davis Pharmaceutical Company. This is a study for patients who have severe osteoarthritis of the knee to try a new nonsteroidal medication if they do not have gastric or duodenal ulceration or severe erosive disease. We performed the endoscopic evaluation of these patients. This is done in conjunction with the research nurses at PruCare under Linda Zincovich and Nilda Freire-Jessmore.

6/04 – "Naturalistic Study of Asacol Dosing Patterns and Outcomes in the Treatment of Ulcerative Colitis." This is done with the Cetus Group as part of a luti-site study on the treatment of ulcerative colitis in acute flare with Asacol in various dosing and outcomes.